International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
Sergio Giralt(The University of Texas MD Anderson Cancer Center), Edward A. Stadtmauer(University of Pennsylvania), Jean‐Luc Harousseau, Antonio Palumbo(Azienda Ospedaliero Universitaria San Giovanni Battista), Jack W. Singer(Fred Hutch Cancer Center), Raymond L. Comenzo(Memorial Sloan Kettering Cancer Center), Shaji Kumar(Mayo Clinic in Arizona), Nikhil C. Munshi(Dana-Farber Cancer Institute), Angela Dispenzieri(WinnMed), Robert A. Kyle(Mayo Clinic), Giampaolo Merlini, Jesús F. San Miguel(Centro de Investigación del Cáncer), Heinz Ludwig(Wilhelminen Hospital), Roman Hájek(Masaryk University), Sundar Jagannath(Catholic Medical Center), Joan Bladé(Hospital Clínic de Barcelona), Sagar Lonial(Emory University), Meletios Α. Dimopoulos(National and Kapodistrian University of Athens), Hermann Einsele(University of Würzburg), Bart Barlogie, Kenneth C. Anderson(Dana-Farber Cancer Institute), Morie A. Gertz(Mayo Clinic), Michel Attal(Hôpital Purpan), Patrizia Tosi(University of Bologna), Pieter Sonneveld(Erasmus MC), Mario Boccadoro(University of Turin), Gareth J. Morgan, Orhan Sezer, María‐Victoria Mateos(Centro de Investigación del Cáncer), Michèle Cavo(Istituto Oncologico Romagnolo), D. Joshua(Royal Prince Alfred Hospital), Ingemar Turesson(Malmö University), W Chen(Capital Medical University), Kazuyuki Shimizu, R Powles(Parkside Hospital), Paul G. Richardson(Dana-Farber Cancer Institute), Rubén Niesvizky(Cornell University), S. Vincent Rajkumar(WinnMed), B G M Durie(Cedars-Sinai Medical Center), on behalf of the IMWG
Cited by 230
Abstract
Related Papers
No related papers found
Powered by citation graph analysis